The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
Can we safely target the WNT pathway?
Open accessAbstract
WNT–β-catenin signalling is involved in a multitude of developmental processes and the maintenance of adult tissue homeostasis by regulating cell proliferation, differentiation, migration, genetic stability and apoptosis, as well as by maintaining adult stem cells in a pluripotent state. Not surprisingly, aberrant regulation of this pathway is therefore associated with a variety of diseases, including cancer, fibrosis and neurodegeneration. Despite this knowledge, therapeutic agents specifically targeting the WNT pathway have only recently entered clinical trials and none has yet been approved. This Review examines the problems and potential solutions to this vexing situation and attempts to bring them into perspective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–295 of 295
Synaptic Wnt signaling—a contributor to major psychiatric disorders?
Okerlund, N. D., & Cheyette, B. N. R. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9083-6 · Cited by 151
Expression of frizzled‐related protein and Wnt‐signalling molecules in invasive human breast tumours
Wong, S. C. C., Lo, S. F. E., Lee, K. C., Yam, J. W. P., Chan, J. K. C., & Hsiao, W. L. W. (2001) · The Journal of Pathology · doi:10.1002/path.1035 · Cited by 149
Induction of a β-catenin-LEF-1 complex by wnt-1 and transforming mutants of β-catenin
Porfiri, E., Rubinfeld, B., Albert, I., Hovanes, K., Waterman, M. L., & Polakis, P. G. (1997) · Oncogene · doi:10.1038/sj.onc.1201462 · Cited by 148
Differentiation of the brain vasculature: the answer came blowing by the Wnt
Liebner, S., & Plate, K. H. (2010) · Vascular Cell · doi:10.1186/2040-2384-2-1 · Cited by 145
Drier, Y., Lawrence, M. S., Carter, S. L., Stewart, C., Gabriel, S., Lander, E. S., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2012) · Genome Research · doi:10.1101/gr.141382.112 · Cited by 145
Regulation of c-myc expression by Ras/Raf signalling
Kerkhoff, E., Houben, R., Löffler, S., Troppmair, J., Lee, J., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201520 · Cited by 144
A review of the evidence for the canonical Wnt pathway in autism spectrum disorders
Kalkman, H. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-10 · Cited by 142
Wnt Signaling in Skeletal Muscle Dynamics: Myogenesis, Neuromuscular Synapse and Fibrosis
Cisternas, P., Henríquez, J. P., Brandan, E., & Inestrosa, N. C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8540-5 · Cited by 142
Wnt proteins promote neuronal differentiation in neural stem cell culture
Muroyama, Y., Kondoh, H., & Takada, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.023 · Cited by 139
R-spondin1, A Novel Intestinotrophic Mitogen, Ameliorates Experimental Colitis in Mice
Zhao, J., Vera, J. D., Narushima, S., Beck, E. X., Palencia, S., Shinkawa, P., Kim, K., Liu, Y., Levy, M. D., Berg, D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.001 · Cited by 139
Loss of beta-catenin expression associated with disease progression in malignant melanoma
Kageshita, T., Hamby, C. V., Ishihara, T., Matsumoto, K., Saida, T., & Ono, T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04336.x · Cited by 138
Lugli, A., Zlobec, I., Minoo, P., Baker, K., Tornillo, L., Terracciano, L., & Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02620.x · Cited by 138
Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco, N., Aguilera, O., Pereira, F., González‐Sancho, J. M., & Múñoz, A. (2008) · PubMed · Cited by 137
Maier, T. J., Janssen, A., Schmidt, R., Geißlinger, G., & Grösch, S. (2005) · The FASEB Journal · doi:10.1096/fj.04-3274fje · Cited by 136
The importance of Wnt signalling for neurodegeneration in Parkinson's disease
Berwick, D. C., & Harvey, K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120122 · Cited by 135
Expression Profiles and Functional Analyses of Wnt-Related Genes in Human Joint Disorders
Nakamura, Y., Nawata, M., & Wakitani, S. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62957-4 · Cited by 133
Traf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth
Shitashige, M., Satow, R., Jigami, T., Aoki, K., Honda, K., Shibata, T., Ono, M., Hirohashi, S., & Yamada, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0306 · Cited by 133
Zhao, C., Avilés, C., Abel, R., Almli, C. R., McQuillen, P. S., & Pleasure, S. J. (2005) · Development · doi:10.1242/dev.01871 · Cited by 129
Bhanja, P., Saha, S., Kabarriti, R., Liu, L., Roy‐Chowdhury, N., Roy‐Chowdhury, J., Sellers, R. S., Alfieri, A. A., & Guha, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008014 · Cited by 128
Role of the Wnt Pathway in Thyroid Cancer
Sastre-Perona, A., & Santisteban, P. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00031 · Cited by 127
Abiola, M., Favier, M., Christodoulou‐Vafeiadou, E., Pichard, A., Martelly, I., & Guillet-Deniau, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008509 · Cited by 126
Wnt4 action in gonadal development and sex determination
Bernard, P., & Harley, V. R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.007 · Cited by 126
Meigs, T. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021350998 · Cited by 126
Faunes, F., Hayward, P. C., Muñoz‐Descalzo, S., Chatterjee, S. S., Balayo, T., Trott, J., Christoforou, A., Ferrer‐Vaquer, A., Hadjantonakis, A., DasGupta, R., et al. (2013) · Development · doi:10.1242/dev.085654 · Cited by 125
A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
El-Khoueiry, A. B., Ning, Y., Yang, D., Cole, S., Kahn, M. R., Zoghbi, M., Berg, J., Fujimori, M., Inada, T., Kouji, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2501 · Cited by 125
Self-citationWnts in action: from synapse formation to synaptic maintenance
Dickins, E. M., & Salinas, P. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00162 · Cited by 124
Wnt signaling in ovarian tumorigenesis
Gatcliffe, T. A., Monk, B. J., Planutis, K., & Holcombe, R. F. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01127.x · Cited by 124
Flozak, A. S., Lam, A. P., Russell, S., Jain, M., Peled, O. N., Sheppard, K. A., Beri, R., Mutlu, G. M., Budinger, G. R. S., & Gottardi, C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070326 · Cited by 123
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Little, R. D., Recker, R. R., & Johnson, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200209193471216 · Cited by 123
Tumor formation due to abnormalities in the β‐catenin‐independent pathway of Wnt signaling
Kikuchi, A., & Yamamoto, H. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00675.x · Cited by 118
Trans-repression of β-Catenin Activity by Nuclear Receptors
Shah, S., Hecht, A., Pestell, R. G., & Byers, S. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307154200 · Cited by 116
Rasola, A., Fassetta, M., Bacco, F. D., D'Alessandro, L., Gramaglia, D., Renzo, M. F. D., & Comoglio, P. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209859 · Cited by 116
Millar, J. K., Christie, S., Semple, C. A. M., & Porteous, D. J. (2000) · Genomics · doi:10.1006/geno.2000.6239 · Cited by 114
Coluccia, A. M. L., Benati, D., Dekhil, H., Filippo, A. D., Lan, C., & Gambacorti-Passerini, C. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2057 · Cited by 113
Targeting Wnt Pathways in DiseasePreprint
Zimmerman, Z. F., Moon, R. T., & Chien, A. J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008086 · Cited by 111
Looking beyond the Wnt pathway for the deep nature of β‐catenin
Fagotto, F. (2013) · EMBO Reports · doi:10.1038/embor.2013.45 · Cited by 109
Milovanović, T., Planutis, K., Nguyen, A. V. P., Marsh, J., Lin, F., Hope, C., & Holcombe, R. F. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.5.1337 · Cited by 106
Carter, M. D., Chen, X., Slowinska, B., Minnerath, S., Glickstein, S. B., Shi, L., Campagne, F., Weinstein, H., & Ross, M. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501963102 · Cited by 104
Jacob, L. S., Wu, X., Dodge, M. E., Fan, C.-W., Kulak, O., Chen, B., Tang, W., Wang, B., Amatruda, J. F., & Lum, L. (2011) · Science Signaling · doi:10.1126/scisignal.2001225 · Cited by 102
Wei, W., Chua, M., Grepper, S., & So, S. K. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-16 · Cited by 101
β-Catenin in the Alveolar Epithelium Protects from Lung Fibrosis after Intratracheal Bleomycin
Tanjore, H., Degryse, A. L., Crossno, P. F., Xu, X. C., McConaha, M. E., Jones, B. R., Polosukhin, V. V., Bryant, A. J., Cheng, D., Newcomb, D. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0972oc · Cited by 100
Le, N. H., Franken, P., & Fodde, R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604401 · Cited by 99
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
Han, Z. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163752 · Cited by 98
Wnt/β‐catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
Wend, P., Fang, L., Zhu, Q., Schipper, J. H., Loddenkemper, C., Kosel, F., Brinkmann, V., Eckert, K., Hindersin, S., Holland, J. D., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.127 · Cited by 97
Self-citationTyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity
Zhou, L., An, N., Haydon, R. C., Zhou, Q., Cheng, H., Peng, Y., Jiang, W., Luu, H. H., Vanichakarn, P., Szatkowski, J. P., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00013-2 · Cited by 94
Radiation and Pituitary Dysfunction
Shalet, S. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280211 · Cited by 94
Investigating Wnt signaling: a chemogenomic safari
McMillan, M., & Kahn, M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03613-5 · Cited by 91
Self-citationSasaki, T., Hwang, H., Nguyen, C., Kloner, R. A., & Kahn, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075010 · Cited by 91
Self-citationPode‐Shakked, N., Harari‐Steinberg, O., Haberman-Ziv, Y., Rom‐Gross, E., Bahar, S., Omer, D. S., Metsuyanim, S., Buzhor, E., Jacob–Hirsch, J., Goldstein, R. S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.549 · Cited by 89
Previdi, S., Maroni, P., Matteucci, E., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.036 · Cited by 89
Takamoto, I., Kubota, N., Nakaya, K., Kumagai, K., Hashimoto, S., Kubota, T., Inoue, M., Kajiwara, E., Katsuyama, H., Obata, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3131-6 · Cited by 89
Wnt signaling enhances the activation and survival of human hepatic stellate cells
Myung, S. J., Yoon, J., Gwak, G., Kim, W. K., Lee, J., Kim, K. M., Shin, C. S., Jang, J. J., Lee, S.-H., Lee, S., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.050 · Cited by 88
Structure-Based Discovery of a Novel Inhibitor Targeting the β-Catenin/Tcf4 Interaction
Wang, T., Han, X., Yan, M., Xu, Y., Duggineni, S., Lin, N., Luo, G., Li, Y. M., Han, X., Huang, Z., et al. (2011) · Biochemistry · doi:10.1021/bi201428h · Cited by 88
Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
Rao, C. V., Desai, D. H., Rivenson, A., Simi, B., Amin, S., & Reddy, B. S. (1995) · PubMed · Cited by 87
Wnt-signalling and the Metabolic Syndrome
Schinner, S. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1119408 · Cited by 87
Methylation‐associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers
Takada, T., Yagi, Y., Maekita, T., Imura, M., Nakagawa, S., Tsao, S., Miyamoto, K., Yoshino, O., Yasugi, T., Taketani, Y., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03255.x · Cited by 87
Axin Pathway Activity Regulates in Vivo pY654-β-catenin Accumulation and Pulmonary Fibrosis
Ulsamer, A., Wei, Y., Kim, K. K., Tan, K., Wheeler, S. E., Xi, Y., Thies, R. S., & Chapman, H. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322123 · Cited by 84
Mælandsmo, G. M., Holm, R., Nesland, J. M., Fodstad, Ø., & Flørenes, V. A. (2003) · PubMed · Cited by 83
Smith, D. C., Rosen, L. S., Chugh, R. K., Goldman, J. W., Xu, L., Kapoun, A. M., Brachmann, R. K., Dupont, J., Stagg, R., Tolcher, A. W., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2540 · Cited by 81
TCF1 and β-catenin regulate T cell development and function
Yu, Q., Sharma, A., & Sen, J. M. (2010) · Immunologic Research · doi:10.1007/s12026-009-8137-2 · Cited by 80
White, B. D., Nathe, R. J., Maris, D. O., Nguyen, N. K., Goodson, J. M., Moon, R. T., & Horner, P. J. (2009) · Stem Cells · doi:10.1002/stem.268 · Cited by 76
Cancer genetics: colorectal cancer as a model
Bodmer, W. F. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0373-x · Cited by 76
Okino, K., Nagai, H., Hatta, M., Nagahata, T., Yoneyama, K., Ohta, Y., Jin, E., Kawanami, O., Araki, T., & Emi, M. (2003) · Oncology Reports · doi:10.3892/or.10.5.1219 · Cited by 75
Roccaro, A. M., Leleu, X. P., Sacco, A., Moreau, A., Hatjiharissi, E., Jia, X., Xu, L., Ciccarelli, B. T., Patterson, C. J., Ngo, H. T., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1750 · Cited by 75
Chen, Z., Venkatesan, A. M., Dehnhardt, C. M., dos Santos, O., Santos, E. D., Ayral‐Kaloustian, S., Chen, L., Geng, Y., Arndt, K. T., Lucas, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.070 · Cited by 74
WNT5A Signaling Contributes to Aβ-Induced Neuroinflammation and Neurotoxicity
Li, B., Zhong, L., Yang, X., Andersson, T., Huang, M., & Tang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022920 · Cited by 71
Canonical Wnt signalling as a key regulator of fibrogenesis – implications for targeted therapies?
Dees, C., & Distler, J. H. W. (2013) · Experimental Dermatology · doi:10.1111/exd.12255 · Cited by 71
Nemeth, M. J., Mak, K. K., Yang, Y., & Bodine, D. M. (2009) · Stem Cells · doi:10.1002/stem.32 · Cited by 70
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
Wagh, P. K., Gray, J. K., Zinser, G. M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.86 · Cited by 68
Increased risk of solid renal tumors in lithium-treated patients
Zaidan, M., Stucker, F., Stengel, B., Vasiliu, V., Hummel, A., Landais, P., Boffa, J., Ronco, P. M., Grünfeld, J., & Servais, A. (2014) · Kidney International · doi:10.1038/ki.2014.2 · Cited by 67
A Wnt-er Migration: The Confusing Role of β-Catenin in Melanoma Metastasis
Webster, M. R., & Weeraratna, A. T. (2013) · Science Signaling · doi:10.1126/scisignal.2004114 · Cited by 66
He, K., Xu, T., Xu, Y., Ring, A., Kahn, M., & Goldkorn, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28341 · Cited by 65
Self-citationNoncanonical Wnt/PCP Signaling During Vertebrate Gastrulation
Tada, M., & Kai, M. (2009) · Zebrafish · doi:10.1089/zeb.2008.0566 · Cited by 64
FP Prostanoid Receptor Activation of a T-cell Factor/β-Catenin Signaling Pathway
Fujino, H., & Regan, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100039200 · Cited by 63
Kim, Y., Ma, H., Oehler, V. G., Gang, E. J., Nguyen, C., Masiello, D., Liu, H., Zhao, Y., Radich, J. P., & Kahn, M. R. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794328420 · Cited by 60
Self-citationThe Wnt Signaling Pathway in Retinal Degenerations
Hackam, A. S. (2005) · IUBMB Life · doi:10.1080/15216540500137586 · Cited by 58
Clements, W. M., Lowy, A., & Groden, J. (2003) · Clinical colorectal cancer · doi:10.3816/ccc.2003.n.018 · Cited by 58
Hasegawa, K., Yasuda, S.-Y., Teo, J.-L., Nguyen, C., McMillan, M., Hsieh, C., Suemori, H., Nakatsuji, N., Yamamoto, M., Miyabayashi, T., et al. (2011) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0033 · Cited by 56
Self-citationSymmetric Division Versus Asymmetric Division: A Tale of Two Coactivators
Kahn, M. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.126 · Cited by 47
Self-citationHahne, G., & Grossmann, T. N. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.050 · Cited by 46
Kim, K., Daniels, K. J., & Hay, E. D. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4238 · Cited by 45
Oral Hedgehog-Pathway Inhibitors for Basal-Cell Carcinoma
Lear, J. T. (2012) · New England Journal of Medicine · doi:10.1056/nejme1202170 · Cited by 44
β-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer
Bakker, E. R. M., Hoekstra, E., Franken, P., Helvensteijn, W., van Deurzen, C. H. M., van Veelen, W., Kuipers, E. J., & Smits, R. (2012) · Oncogene · doi:10.1038/onc.2012.449 · Cited by 39
Rawson, J. B., Mrkonjic, M., Daftary, D., Dicks, E. L., Buchanan, D. D., Younghusband, H. B., Parfrey, P. S., Young, J. P., Pollett, A. F., Green, R. C., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.165 · Cited by 39
Aly, H., Rohatgi, N., Marshall, C. A., Grossenheider, T. C., Miyoshi, H., Stappenbeck, T. S., Matkovich, S. J., & McDaniel, M. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066131 · Cited by 38
Lukaszewicz, A. I., McMillan, M., & Kahn, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901361d · Cited by 37
Self-citationThe Role of the APC Tumor Suppressor in Chromosomal Instability
Alberici, P., & Fodde, R. (2006) · KARGER eBooks · doi:10.1159/000092506 · Cited by 36
Yao, J., Qian, C., Shu, T., Zhang, X., Zhao, Z., & Liang, Y. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25332 · Cited by 34
Morishita, E. C., Murayama, K., Kato-Murayama, M., Ishizuka‐Katsura, Y., Tomabechi, Y., Hayashi, T., Terada, T., Handa, N., Shirouzu, M., Akiyama, T., et al. (2011) · Structure · doi:10.1016/j.str.2011.07.013 · Cited by 34
Beta-Catenin Versus the Other Armadillo Catenins
Miller, R. K., Hong, J. Y., Muñoz, W. A., & McCrea, P. D. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394311-8.00017-0 · Cited by 33
Chemical ‘Jekyll and Hyde’s: small-molecule inhibitors of developmental signaling pathways
Sakata, T., & Chen, J. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15019g · Cited by 33
Considerations for Targeting β-Catenin Signaling in Fibrosis
Gottardi, C. J., & Königshoff, M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0144ed · Cited by 29
Kajiguchi, T., Katsumi, A., Tanizaki, R., Kiyoi, H., & Naoe, T. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01738.x · Cited by 26
Bcr interferes with β‐catenin–Tcf1 interaction
Reß, A., & Moelling, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.034 · Cited by 18
García‐Jiménez, C. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00014-x · Cited by 15
Cited by
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., Zhou, Z., Shu, G., & Yin, G. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00762-6 · Cited by 2,519
Metadata
- Authors
- Kahn, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-07
- Volume
- 13
- Issue
- 7
- Pages
- 513-532
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1994928797
- Cited by
- 1,034
- References
- 295
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.